复发/转移性头颈部鳞癌免疫检查点抑制剂治 疗专家共识（2024年版）.
- Published in:
- China Oncology, 2024, v. 34, n. 4, p. 425, doi. 10.19401/j.cnki.1007-3639.2024.04.010
- By:
- Publication type:
- Article
Works matching IS 10073639 AND DT 2024 AND VI 34 AND IP 4
Results: 11
1
2
基于深度学习算法的病理学图片淋巴细胞浸润 检测.
- Published in:
- China Oncology, 2024, v. 34, n. 4, p. 409, doi. 10.19401/j.cnki.1007-3639.2024.04.008
- By:
- Publication type:
- Article
3
托法替布治疗激素抵抗型免疫检查点抑制剂 相关心肌炎的临床研究.
- Published in:
- China Oncology, 2024, v. 34, n. 4, p. 400, doi. 10.19401/j.cnki.1007-3639.2024.04.007
- By:
- Publication type:
- Article
4
12例子宫外低级别子宫内膜间质肉瘤患者的 回顾性分析及文献复习.
- Published in:
- China Oncology, 2024, v. 34, n. 4, p. 418, doi. 10.19401/j.cnki.1007-3639.2024.04.009
- By:
- Publication type:
- Article
5
HMGA2对软脑膜转移黑色素瘤细胞迁移和增 殖的影响.
- Published in:
- China Oncology, 2024, v. 34, n. 4, p. 389, doi. 10.19401/j.cnki.1007-3639.2024.04.006
- By:
- Publication type:
- Article
6
EGFR T790M突变非小细胞肺癌患者的临床 病理学、免疫微环境特征及对预后预测的意义
- Published in:
- China Oncology, 2024, v. 34, n. 4, p. 368, doi. 10.19401/j.cnki.1007-3639.2024.04.004
- By:
- Publication type:
- Article
7
MRI鉴别宫颈腺体叶状增生与宫颈胃型腺癌的 价值.
- Published in:
- China Oncology, 2024, v. 34, n. 4, p. 380, doi. 10.19401/j.cnki.1007-3639.2024.04.005
- By:
- Publication type:
- Article
8
观察性流行病学研究的报告指南--STROBE声明.
- Published in:
- China Oncology, 2024, v. 34, n. 4, p. 399
- Publication type:
- Article
9
572例宫颈癌远处转移患者的转移特征及生存 分析: 以医院为基础的真实世界研究
- Published in:
- China Oncology, 2024, v. 34, n. 4, p. 361, doi. 10.19401/j.cnki.1007-3639.2024.04.003
- By:
- Publication type:
- Article
10
2023年度妇科恶性肿瘤治疗进展及展望.
- Published in:
- China Oncology, 2024, v. 34, n. 4, p. 340, doi. 10.19401/j.cnki.1007-3639.2024.04.002
- By:
- Publication type:
- Article
11
023年度肺癌外科治疗领域重要进展.
- Published in:
- China Oncology, 2024, v. 34, n. 4, p. 335, doi. 10.19401/j.cnki.1007-3639.2024.04.001
- By:
- Publication type:
- Article